KNSA
Kiniksa Pharmaceuticals International
$76.48
−$2.04 (−2.6%)Sep 10, 2026
Key metrics
The numbers that frame KNSA today
- Market cap
- $5.97B
- P/E (TTM)
- 74.0
- EV / FCF
- 31.7
- Gross margin
- 89.8%
- EV / Sales
- 6.9
- ROIC
- 24.3%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $35.20
- 52wk High
- $82.94
Growth
Revenue and earnings trend for KNSA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KNSA
Is Kiniksa Pharmaceuticals International a good buy?
Yes. Kiniksa Pharmaceuticals International has strong quality and excellent momentum. Both signals support the setup. Growth looks strong, which supports the long-term business case. We think Kiniksa Pharmaceuticals International is selling at a fair price.
What is the market capitalization of KNSA?
Kiniksa Pharmaceuticals International's market capitalization is $5.97B.
What is the P/E ratio for KNSA stock?
Kiniksa Pharmaceuticals International's current P/E ratio is 74.
What is the 52-week high for KNSA stock?
The 52-week high for Kiniksa Pharmaceuticals International is $82.94. The current close of $76.48 is 7.8% below that high.
What is the 52-week low for KNSA stock?
The 52-week low for Kiniksa Pharmaceuticals International is $35.20. The current close of $76.48 is 117.3% above that low.
Does KNSA stock pay dividends?
Kiniksa Pharmaceuticals International does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KNSA?
Kiniksa Pharmaceuticals International's Debt / Equity ratio is 0.01.